| Product Name | MF | CAS | Details |
|---|
| Ranibizumab | C11H12N2O2 | 347396-82-1 | Details |
| IFN-γ | 284690-33-1 | Details |
| Details |
| Atezolizumab | 1380723-44-3 | Details |
| Pembrolizumab | 1374853-91-4 | Details |
| Trastuzumab | Details |
| Ustekinumab | 815610-63-0 | Details |
| Cetuximab | C107H179N35O36S7 | 205923-56-4 | Details |
| EPO | C22H22ClKN6O | 11096-26-7 | Details |
| Nivolumab | 946414-94-4 | Details |
| Insulin | C256H381N65O76S6 | 12584-58-6 | Details |
| Alemtuzumab | 216503-57-0 | Details |
| Bevacizumab | C6638H10160N1720O2108S44 | 216974-75-3 | Details |
| Obinutuzumab | Details |
| Alirocumab | 1245916-14-6 | Details |
| Avelumab | 1537032-82-8 | Details |
| Pertuzumab | C17H27NO2 | 380610-27-5 | Details |
| Adalimumab | C6428H9912N1694O1987S46 | 331731-18-1 | Details |
| pd-L1 | Details |
| Details |
| Product Total： Product Page： | ||||
| 1 | ||||